JPRN-UMIN000037106Recruiting未知
Clinical study of GLP-1 receptor agonist (Exenatide) for type 2 diabetes patients with diabetic nephropathy - Clinical study of exenatide for type 2 diabetes patients with diabetic nephropathy
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Kagawa University
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 80years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who fall under any of the following are excluded from this clinical study. 1) Patients who fall under the contraindication for GLP-1 receptor agonist 2) Patients participating in other clinical research 3) Pregnant women, pregnant women, lactating women or women who may have pregnancy 4) Patients with other serious complications 5) Patients judged to be unsuitable as a target by the judgment of other doctors
Investigators
Similar Trials
Active, not recruiting
Phase 1
Effet d’un agoniste du récepteur au GLP1 (Exenatide) sur le contenu en triglycérides intramyocardique chez le patient obèse diabétique.patient obèse diabétiqueEUCTR2010-022792-57-FRASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE40
Active, not recruiting
Phase 1
To investigate whether treatment with the GLP-1 receptor agonist exenatide improves the perception of hypoglycaemia in people with type 1 diabetes with impaired awareness of hypoglycaemiaType 1 diabetesEUCTR2016-000790-21-NLRadboudumc15
Completed
Phase 2
Effect of the GLP-1 receptor agonist exenatide on impaired awareness of hypoglycemia in type 1 diabetesDiabetesNL-OMON45806Radboud Universitair Medisch Centrum13
Recruiting
Not Applicable
Observation of using GLP-1 receptor agonist for wellness of brain activity in type 2 diabetes patients with mild cognitive impairmentJPRN-UMIN000030840Ogawa Red Cross Hospital50
Completed
Not Applicable
The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and DiabetesDiabetes MellitusObesityDiabetes Mellitus, Type 2NCT01281228Amsterdam UMC, location VUmc48